FIDE delivers dermatology consulting services and educational programs to the biotechnology, medical device, and pharmaceutical industries, as well as to the wider healthcare industry. We provide our clients with direct and unbiased views on clinical data and offer a full suite of services, including the FIDE Conference Analysis Program (CAP), strategic consulting, competitor analysis, market insight reports, and pipeline and portfolio strategy.  Our expertise spans the pathophysiology, clinical presentation, and treatment of chronic dermatology indications, including psoriasis, psoriatic arthritis, atopic dermatitis, hidradenitis suppurativa, alopecia areata, and vitiligo. Our expert-led approach differs from conventional consultancy. We’re a network of more than 25 leading KOLs—including Dr. Bruce Strober, Dr. Ken Gordon and Dr. Richard Langley, that combines the latest therapy area intelligence with strategic consulting to improve healthcare outcomes and optimize business goals.